Patents by Inventor Kyle R. COVINGTON

Kyle R. COVINGTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of diagnosing and treating patients with cutaneous squamous cell carcinoma
    Patent number: 11976331
    Abstract: The present disclosure relates to methods for predicting the risk of recurrence and/or metastasis, or both in primary cutaneous squamous cell carcinoma (cSCC).
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: May 7, 2024
    Assignee: CASTLE BIOSCIENCES, INC.
    Inventors: Robert Willis Cook, Kyle R. Covington, Derek Maetzold, Sarah J Kurley
  • Methods of diagnosing and treating patients with cutaneous squamous cell carcinoma
    Patent number: 11976333
    Abstract: The present disclosure relates to methods for predicting the risk of recurrence and/or metastasis, or both in primary cutaneous squamous cell carcinoma (cSCC).
    Type: Grant
    Filed: August 14, 2020
    Date of Patent: May 7, 2024
    Assignee: CASTLE BIOSCIENCES, INC.
    Inventors: Robert Willis Cook, Kyle R. Covington, Derek Maetzold, Sarah J Kurley
  • Determining Prognosis and Treatment based on Clinical-Pathologic Factors and Continuous Multigene-Expression Profile Scores
    Publication number: 20220285032
    Abstract: Example embodiments relate to determining prognosis and treatment based on clinical-pathologic factors and continuous multigene-expression profile scores. An example embodiment includes a non-transitory, computer-readable medium having instructions stored thereon. The instructions, when executed by a processor, cause the processor to execute a method. The method includes obtaining a plurality of clinical-pathologic factors related to a patient. The clinical-pathologic factors are indicative of risk associated with melanoma. The method also includes obtaining a continuous multigene-expression profile score for the patient. The continuous multigene-expression profile score is based on multiple genes whose expressions are related to melanoma. Further, the method includes determining, based on the plurality of clinical-pathologic factors and the continuous multigene-expression profile score, a risk score for the patient.
    Type: Application
    Filed: March 7, 2022
    Publication date: September 8, 2022
    Applicant: Castle Biosciences, Inc.
    Inventors: Kyle R. COVINGTON, Bernhard SPIESS, Ann QUICK, Sarah KURLEY
  • METHODS OF DIAGNOSING AND TREATING PATIENTS WITH PIGMENTED SKIN LESIONS
    Publication number: 20220033882
    Abstract: The present disclosure relates to methods for diagnosing a skin lesion as malignant or benign.
    Type: Application
    Filed: August 3, 2021
    Publication date: February 3, 2022
    Applicant: CASTLE BIOSCIENCES, INC.
    Inventors: Robert Willis COOK, Derek MAETZOLD, Kyle R. COVINGTON, Olga ZOLOCHEVSKA
  • METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA
    Publication number: 20210238688
    Abstract: The present disclosure relates to methods for predicting the risk of recurrence and/or metastasis, or both in primary cutaneous squamous cell carcinoma (cSCC).
    Type: Application
    Filed: August 14, 2020
    Publication date: August 5, 2021
    Inventors: Robert Willis COOK, Kyle R. COVINGTON, Derek MAETZOLD, Sarah J KURLEY
  • METHODS OF DIAGNOSING AND TREATING PATIENTS WITH CUTANEOUS SQUAMOUS CELL CARCINOMA
    Publication number: 20210238687
    Abstract: The present disclosure relates to methods for predicting the risk of recurrence and/or metastasis, or both in primary cutaneous squamous cell carcinoma (cSCC).
    Type: Application
    Filed: January 31, 2020
    Publication date: August 5, 2021
    Inventors: Robert Willis COOK, Kyle R. COVINGTON, Derek MAETZOLD, Sarah J. KURLEY